Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202

Clinical trial NCT02772627 · COMPLETED

Trial details

NCT number: NCT02772627
Sponsor: Bial - Portela C S.A.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2001-09-01
Primary completion: 2001-12-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.